ALLMedicine™ Optic Neuritis Center

Mar 4th, 2021 - Vascular damage may mimic retinitis and optic neuritis in COVID-19.|2021|Finsterer J,Scorza FA,Scorza CA,Fiorini AC,|

Mar 1st, 2021 - Tumour Necrosis Factor alpha (TNFα) blockers are common and effective treatments for several autoimmune diseases but can be associated with neuroinflammatory events. We describe the disease course of ten patients who developed CNS demyelinating ev...

Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...

Feb 19th, 2021 - Bruch's membrane opening-minimum rim width (BMO-MRW) and RNFL measured using anatomic positioning system (APS-RNFL) are novel OCT methods and remained unexplored in MS patients.To investigate the novel parameters of spectral-domain OCT as an alter...

Feb 8th, 2021 - The object of the study is to relate the pattern reversal visual evoked potential (PRVEP) and flash VEP (f-VEP) latencies with retinal neurons and their fibers. We studied 104 eyes. Forty-two eyes from patients with optic neuritis (ON), 28 eyes fr...

In December 2019, a novel coronavirus (CoV) epidemic, caused by the severe acute respiratory syndrome coronavirus – 2 (SARS-CoV-2) emerged from China. This virus causes the coronavirus disease 2019 (COVID-19). Since then, there have been anecdotal...

Mar 4th, 2021 - Vascular damage may mimic retinitis and optic neuritis in COVID-19.|2021|Finsterer J,Scorza FA,Scorza CA,Fiorini AC,|

Mar 3rd, 2021 - Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a phase 3 randomized controlled trial. "EPO conve...

Mar 1st, 2021 - Tumour Necrosis Factor alpha (TNFα) blockers are common and effective treatments for several autoimmune diseases but can be associated with neuroinflammatory events. We describe the disease course of ten patients who developed CNS demyelinating ev...

Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...

Feb 19th, 2021 - Bruch's membrane opening-minimum rim width (BMO-MRW) and RNFL measured using anatomic positioning system (APS-RNFL) are novel OCT methods and remained unexplored in MS patients.To investigate the novel parameters of spectral-domain OCT as an alter...

Mar 3rd, 2021 - Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a phase 3 randomized controlled trial. "EPO conve...

Apr 7th, 2020 - Figure 1. Optic neuritis with drusen (stereo image). The most common visual disturbance associated with MS is ON or inflammation of the optic nerve characterized by a subacute unilateral vision loss, flashes of light, and typically pain with eye m...

Apr 7th, 2020 - In RIS, clinical symptoms of MS are absent, but McDonald imaging criteria for MS are met. RIS MRI demonstrates the McDonald criteria of DIS; however, clinical symptoms of MS are absent. Two thirds of these patients have radiologic progression and ...

Jan 3rd, 2019 - A 79-year-old man presented with sudden-onset bilateral weakness in the lower and upper extremities that had started 6 hours earlier. He reported no vision disturbances or urinary incontinence.

Jan 2nd, 2019 - Thinking about mistakes, especially medical mistakes, is uncomfortable. It is certainly more enjoyable to read about a promising new therapy than to scrutinize the reasons that medical mistakes are happening. Yet, medical mistakes are currently th...